Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

September 30, 2016

Study Completion Date

November 30, 2016

Conditions
Ulcerative Colitis
Interventions
DRUG

Rectal tacrolimus

Rectal tacrolimus made as an ointment at a concentration of 0.5mg/ml with 3 mls will be applied rectally twice a day

DRUG

Placebo

Placebo

Trial Locations (4)

6160

Centre for IBD, Fremantle Hospital, Fremantle

Unknown

Liverpool Hospital, Sydney

Royal Brisbane and Women's Hospital, Brisbane

Royal Adelaide Hospital, Adelaide

All Listed Sponsors
collaborator

Royal Brisbane and Women's Hospital

OTHER_GOV

collaborator

Royal Adelaide Hospital, Australia

UNKNOWN

collaborator

Liverpool Hospital, Australia

UNKNOWN

collaborator

Fremantle Hospital and Health Service

OTHER

lead

The University of Western Australia

OTHER

NCT01418131 - Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis | Biotech Hunter | Biotech Hunter